The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26125583
PubMed Central
PMC4488342
DOI
10.1371/journal.pone.0131117
PII: PONE-D-15-10786
Knihovny.cz E-zdroje
- MeSH
- biostatistika MeSH
- epidemiologické monitorování MeSH
- hromadná vakcinace statistika a číselné údaje MeSH
- incidence MeSH
- lidé MeSH
- následné studie MeSH
- očkovací programy statistika a číselné údaje MeSH
- očkovací schéma MeSH
- pneumokokové infekce epidemiologie prevence a kontrola MeSH
- pneumokokové vakcíny aplikace a dávkování MeSH
- programy národního zdraví statistika a číselné údaje MeSH
- vakcíny konjugované aplikace a dávkování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
- Názvy látek
- pneumokokové vakcíny MeSH
- vakcíny konjugované MeSH
BACKGROUND: Invasive pneumococcal disease (IPD) is caused by Streptococcus pneumoniae and mostly presents as pneumonia, sepsis or meningitis. A notable portion of IPD cases is vaccine preventable and the pneumococcal conjugate vaccine (PCV) was introduced into the routine childhood immunization programs in many countries during the last decades. OBJECTIVES: Before PCV introduction in the Czech Republic in 2010, a national surveillance system for IPD was implemented in 2008 and further improved in 2011. In this study, we describe the new surveillance system for the first time and measure its sensitivity between 2010 and 2013 using the capture-recapture method. Furthermore, we describe the recent epidemiological trend of IPD, taking sensitivity estimates into account. RESULTS AND CONCLUSIONS: Between 2010 and 2013 the estimated sensitivity of the overall IPD surveillance increased from 81% to 99%. The sensitivity of individual reporting sources increased from 72% to 87% for the laboratory system and from 31% to 89% for the epidemiological notification system. Crucial for this improvement was the introduction of quarterly report reminders in 2011. Due to positive source dependency, the presented sensitivity estimates are most probably overestimated and reflect the upper limit of reporting completeness. Stratification showed variation in sensitivity of reporting particularly according to region. An effect of the PVC vaccination in the Czech Republic is visible in the incidence of IPD in target age groups (<5 y). This influence was not evident in the total IPD incidence and may interfere with increasing sensitivity of reporting. In 2013, an increase in the IPD incidence was observed. This finding requires further observation and a detailed vaccine impact analysis is needed to assess the current immunization strategy.
Zobrazit více v PubMed
Donkor ES (2013) Understanding the pneumococcus: transmission and evolution. Front Cell Infect Microbiol 3: 7 10.3389/fcimb.2013.00007 PubMed DOI PMC
Randle E, Ninis N, Inwald D (2011) Invasive pneumococcal disease. Arch Dis Child Educ Pract Ed 96: 183–190. 10.1136/adc.2010.191718 PubMed DOI
ECDC (2012) Surveillance of invasive pneumococcal disease in Europe, 2010. European Centre for Disease Prevention and Control.
Song JY, Nahm MH, Moseley MA (2013) Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci 28: 4–15. 10.3346/jkms.2013.28.1.4 PubMed DOI PMC
Hanquet G, Perrocheau A, Kissling E, Bruhl DL, Tarrago D, Stuart J, et al. (2010) Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system? Vaccine 28: 3920–3928. 10.1016/j.vaccine.2010.03.069 PubMed DOI
Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14: e197–209. 10.1016/j.ijid.2009.05.010 PubMed DOI
Motlova J, Benes C, Kriz P (2009) Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997–2006. Epidemiol Infect 137: 562–569. 10.1017/S0950268808001301 PubMed DOI
Pebody RG, Hellenbrand W, D'Ancona F, Ruutu P (2006) Pneumococcal disease surveillance in Europe. Euro Surveill 11: 171–178. PubMed
ECDC (2013) Surveillance of invasive bacterial diseases in Europe, 2011. European Centre for Disease Prevention and Control;
Hanquet G, Lernout T, Vergison A, Verhaegen J, Kissling E, Tuerlinckx D, et al. (2011) Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. Vaccine 29: 2856–2864. 10.1016/j.vaccine.2011.02.016 PubMed DOI
Savulescu C, Hanquet G, SpIDnet-group. Impact of higher-valency conjugate vaccines on invasive pneumococcal disease: preliminary results of a European multicentre project; 2014; Dublin, Ireland.
Brenner H (1995) Use and limitations of the capture-recapture method in disease monitoring with two dependent sources. Epidemiology 6: 42–48. PubMed
Tilling K (2001) Capture-recapture methods—useful or misleading? Int J Epidemiol 30: 12–14. PubMed
Hook EB, Regal RR (1992) The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol 135: 1060–1067. PubMed
Tilling K, Sterne JAC (1999) Capture-recapture models including covariate effects. Am J Epidemiol 149: 392–400. PubMed
Farrington CP (2002) Interval estimation for Poisson capture-recapture models in epidemiology. Stat Med 21: 3079–3092. PubMed
R_Core_Team (2013) R: A language and Environment for Statistical Computing.
Sekar CC, Deming WE (1949) On a Method of Estimating Birth and Death Rates and the Extent of Registration. Journal of the American Statistical Association 44: 101–115.
German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN, et al. (2001) Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 50: 1–35; quiz CE31-37. PubMed
Gjini A, Stuart JM, George RC, Nichols T, Heyderman RS (2004) Capture-recapture analysis and pneumococcal meningitis estimates in England. Emerg Infect Dis 10: 87–93. PubMed
Howitz MF, Samuelsson S, Molbak K (2008) Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002. Epidemiol Infect 136: 1088–1095. PubMed PMC
Schrauder A, Claus H, Elias J, Vogel U, Haas W, Hellenbrand W (2007) Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003. Epidemiol Infect 135: 657–664. PubMed PMC
Declich S, Carter AO (1994) Public health surveillance: historical origins, methods and evaluation. Bull World Health Organ 72: 285–304. PubMed PMC
Surveillance of pneumococcal diseases in Central and Eastern Europe